Targeting Apoptotic Activity Against Prostate Cancer Stem Cells
Numerous data suggest that an increase of cancer stem cells (CSCs) in tumor mass can be the reason for failure of conventional therapies because of their resistance. CD44+/CD24− cells are a putative cancer stem cells subpopulation in prostate cancer. TRAIL (tumor necrosis factor-related apoptosis-in...
Main Authors: | Dagmara Jaworska, Ewelina Szliszka |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2017-07-01
|
Series: | International Journal of Molecular Sciences |
Subjects: | |
Online Access: | https://www.mdpi.com/1422-0067/18/8/1648 |
Similar Items
-
The role of taxanes in prostate cancer: literature review
by: A. K. Norsov, et al.
Published: (2018-07-01) -
TAXANES IN THE TREATMENT OF CASTRATION-RESISTANT PROSTATE CANCER
by: T. N. Skvortsova, et al.
Published: (2017-01-01) -
Cost-effectiveness analysis of cabazitaxel for metastatic castration resistant prostate cancer after docetaxel and androgen-signaling-targeted inhibitor resistance
by: Peng-Fei Zhang, et al.
Published: (2021-01-01) -
CURRENT POSSIBILITIES OF DRUG THERAPY FOR CASTRATION-RESISTANT PROSTATE CANCER
by: A. S. Markova
Published: (2014-07-01) -
Chemotherapy and its evolving role in the management of advanced prostate cancer
by: Michael T Schweizer, et al.
Published: (2014-06-01)